Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Partnering with us
Working to accelerate biological research, disease diagnosis, and drug discovery together
Introduction

Acro Partnering, the innovation platform of ACROBiosystems Group, is creating an ecosystem for life science tools, reagents, and instruments. We collaborate with businesses, research institutions, and startups to commercialize technologies that are already mature or will be mature within 3-5 years. Together, we serve the ever-growing global customer base of ACROBiosystems Group, which includes pharmaceutical companies, CRO/CDMOs, research institutions, and hospitals.

ACROBiosystems Group, a biotechnology company, aims to be a cornerstone of the global biopharmaceutical and health industries by providing innovative products and business models. Active across the US, Switzerland, the UK, and Germany, with offices in over 10 cities, we have served over 9000 clients and partnered with leading pharmaceutical companies and academic institutes

Focus Areas
Technology Platforms

Cell TherapyHOT

Induced differentiation of cells

Gene editing technology and synthetic biology platforms

Single-cell analysis and evaluation platforms

Cell sorting and activation technology

Scalable cell production technology

Potency evaluation and CMC quality control

Antibody Drugs and XDC Field

Medicinal compound components (Linker, Payload, etc.)

Conjugation technologies

Purification technologies and processes

Large-scale production process

Quality control and assurance systems

Phage display and high-throughput screening platforms

Protein Expression and Purification Field

Expression elements and vector libraries

Cell-free protein expression systems

AI-assisted protein, antibody, and peptide design platforms

Engineered cells and strains

Optimization and modification of protein secretion systems

Inclusion body denaturation and renaturation techniques

Cell lines

Protein, antibody expression, and purification technologies

Gene Therapy HOT

Vector design and screening strategies

Vector tools and RNA delivery platform technologies

Patent-pending gene editing systems (e.g., high-precision editing, epigenetic regulation, etc.)

Development of virus-producing cell lines

Purification technologies and processes

Large-scale production and quality control

RNA modification and detection technologies

Neuroscience and Organoid Field

Rare disease cell and organoid models

Optogenetics and neurostimulation platforms

iPS and other cell sample libraries

Organoid culture-related consumables and reagents

Neural-related ion channel cell lines

Electrophysiology and imaging downstream detection instruments and technologies

Behavioral analysis and microdialysis techniques

Peptide Design and Synthesis

Peptide synthesis technologies (automated, high-yield conjugation)

Peptide mimetics and stable peptide synthesis technologies

Peptide design platforms and high-throughput screening systems

Let's chat

Technology Platforms

Cell and Viral Vectors

Large-scale production and quality control technologies

Cell-Free Expression Platforms

Cell-free protein expression systems

Conjugation Technologies

Biorthogonal chemistries for site-specific conjugations

High-yield and high-stability conjugations

Delivery Technologies

Next-generation biologics delivery platforms (High Payload, Controlled Release, Enhanced Stability)

Biological/Chemical Luminescence Technologies

Innovative solutions for sensitive detection and imaging

AI+

Integration of artificial intelligence in biotechnological applications

Advanced Diagnostic Technologies

Multi-factor analysis platforms, companion diagnostics, IHC, liquid biopsy

Drug Efficacy, Toxicity, and Metabolism Screening Platforms

High-throughput screening systems, organoid-based models

Organ on Chip Platforms

Microfluidic technologies, integrated multi-organ chips

Let's chat

Technology Platforms
Equity Investment
Co-development
Co-marketing
Sponsored Research

*Acro Certify is an innovative initiative from ACROBiosystems Group, crafted to empower our partners' global market entry. It focuses on bolstering sales channels, brand value, quality assurance, and logistics to build brand impact and speed innovation globally.

Partnering Models

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message